ZInvestorHunting

Karl Handelsman

Solo GP · San Francisco, California

Verified Active Check-WriterUS Angel

Named as the only individual (Managing Partner of the Manager of the General Partner of the Fund) on the Form D for Codon Innovation Fund I, LP, a $15M venture fund (Jun 2026). Also a non-executive director at 1 startup that filed Form D.

Investor IntelligenceVerified Activity

Angel Investment Confidence Score

Algorithmic score indicating recent deal velocity, check size reliability, and investment conviction in early-stage startups.

90/ 100
Tier-1 Active Check-Writer1 deals in last 12 months
Deal Velocity1 deals in last 12 monthsUSA & Europe pipeline
Typical Check$150K–$450KPre-Seed / Seed
Primary FocusBiotech & PharmaPre-seed to Series B
Direct AccessWarm Intro Recommended1-click pitch match

Why Karl Handelsman holds a 90/100 confidence score

  • Verified active check-writing activity within the last 12 months
  • Target check sizes calibrated between $150K–$450K
  • Clear domain thesis in Biotech & Pharma
  • Named as the only individual (Managing Partner of the Manager of the General Partner of the Fund) on the Form D for Codon Innovation Fund I, LP, a $15M venture fund (Jun 2026). Also a non-executive director at 1 startup that filed Form D.

Building in Biotech & Pharma? See how well your pitch deck matches Karl Handelsman’s thesis.

Check My Startup Fit

Verified investment track record

Named as the only individual (Managing Partner of the Manager of the General Partner of the Fund) on the Form D for Codon Innovation Fund I, LP, a $15M venture fund (Jun 2026). Also a non-executive director at 1 startup that filed Form D.

Source: SEC Form D: Codon Innovation Fund I, LP (Jun 16, 2026) · 1 more source

Stages
Pre-seed to Series B
Typical check (est.)
$150K–$450K
Verified deals
2 on file
Latest activity
Jun 2026
Pitch Readiness

Is Karl Handelsman a fit for you?

See your AI startup fit score, verified contact channels, and warm paths through your network.

What sectors does Karl Handelsman back?

Biotech & Pharma

Verified investments & deal activity

2 deals tracked

Recent startup investments, syndicate rounds, and public co-investments across the US and Europe.

  • Bonum Therapeutics

    Board seat on the company's SEC filing · WA

    Apr 2026
  • Codon Innovation Fund I, LP

    Invested through a fund

    Jun 2023

Public Verification Sources

Data refreshed from SEC filings and public European announcements Oct 15, 2026. Is this you? Correct or remove this profile.

Syndicate IntelligenceUSA & Europe

Active Angels Similar to Karl Handelsman

Founders raising in bio also reach out to these verified check-writers with similar portfolio focus and check sizes.

View all matching angels
Joseph Fernandes

Syndicate lead · Austin, TX

99/100
$145K–$595KActive Sep 2026
AI & MLBiotech & PharmaCybersecurity+1
Ben Horowitz

Solo GP · Menlo Park, CA

99/100
$75K–$200KActive Sep 2026
AI & MLBiotech & PharmaCrypto & Web3+1
Golden Seeds

Angel group · Scottsdale, AZ

97/100
$125K–$350KActive Oct 2026
HealthcareBiotech & PharmaConsumer+2
David Blivin

Solo GP · Santa Fe, NM

86/100
$800K–$2.4MActive Feb 2026
B2B SoftwareBiotech & PharmaClimate & Energy
Jeffrey Arnold

Solo GP · San Francisco, CA

88/100
Active Aug 2026
Biotech & Pharma
Paul Jun

Solo GP · San Francisco, CA

88/100
Active Aug 2026
Biotech & Pharma
AI Pitch & Angel Matcher

Raising pre-seed or seed for your startup?

Don’t pitch blindly. Our AI engine evaluates your startup against Karl Handelsman and 100+ active US & European angels to deliver 3 perfect matches with tailored warm intros and pitch deck reviews.